Intrapleural paclitaxel for malignant pleural effusion from ovarian and breast cancer: A phase II study with pharmacokinetic analysis

Cancer Chemotherapy and Pharmacology

Volumn 69, Issue 3, 2012, Pages 781-787

  Lombardi, Giuseppe ^a   Nicoletto, Maria Ornella ^a   Gusella, Milena ^b   Fiduccia, Pasquale ^a   Dalla Palma, Maurizia ^a   Zuin, Andrea ^c   Fiore, Davide ^a   Donach, Martin ^a   Zagonel, Vittorina ^a  

^a VENETO INSTITUTE OF ONCOLOGY IOV IRCCS   (Italy)

^b ULSS 18   (Italy)

^c UNIVERSITY OF PADOVA   (Italy)

Author keywords

Breast cancer; Chemotherapy; Malignant pleural effusion; Ovarian cancer; Paclitaxel

Indexed keywords

PACLITAXEL;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; BLOOD SAMPLING; BREAST CANCER; CLINICAL ARTICLE; DISTRIBUTION VOLUME; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG EFFICACY; DRUG FATALITY; DRUG FEVER; DRUG HALF LIFE; DRUG SAFETY; DYSPNEA; FATIGUE; FEMALE; HUMAN; INJECTION SITE EXTRAVASATION; OVARY CANCER; OVERALL SURVIVAL; PHASE 2 CLINICAL TRIAL; PLEURA EFFUSION; PLEURA FLUID; PRIORITY JOURNAL; THORAX DRAINAGE; THORAX PAIN; THORAX RADIOGRAPHY; TREATMENT RESPONSE;

ADULT; AGED; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BREAST NEOPLASMS; DISEASE-FREE SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRAINAGE; FEMALE; HUMANS; INSTILLATION, DRUG; MIDDLE AGED; OVARIAN NEOPLASMS; PACLITAXEL; PLEURAL CAVITY; PLEURAL EFFUSION, MALIGNANT; TISSUE DISTRIBUTION;

EID: 84859775641     PISSN: 03445704     EISSN: 14320843     Source Type: Journal    
DOI: 10.1007/s00280-011-1765-y     Document Type: Article

References (17)

1. Cheng D, Rodriguez RM, Perkett EA, Rogers J, Bienvenu G, Lappalainen U, Light RW (1999) Vascular endothelial growth factor in pleural fluid. Chest 116:760-765 (Pubitemid 29428497)
2. Bennett R, Maskell N (2005) Management of malignant pleural effusions. Curr Opin Pulm Med 11:296-300 (Pubitemid 41073152)
3. Lombardi G, Zustovich F, Nicoletto MO, Donach M, Artioli G, Pastorelli D (2010) Diagnosis and treatment of malignant pleural effusion: a systematic literature review and new approaches. Am J Clin Oncol 33:420-423
4. Janssen JP, Collier G, Astoul P, Tassi GF, Noppen M, Rodriguez-Panadero F, Loddenkemper R, Herth FJ, Gasparini S, Marquette CH, Becke B, Froudarakis ME, Driesen P, Bolliger CT, Tschopp JM (2007) Safety of pleurodesis with talc poudrage in malignant pleural effusion: a prospective cohort study. Lancet 369:1535-1539 (Pubitemid 46670303)
5. Heffner JE, Klein JS (2008) Recent advances in the diagnosis and management of malignant pleural effusions. Mayo Clin Proc 83:235-250 (Pubitemid 351303104)
6. Perng RP, Chen YM, Wu MF, Chou KC, Lin WC, Liu JM, Whang-Peng J (1998) Phase II trial of intrapleural paclitaxel injection for non-small-cell lung cancer patients with malignant pleural effusions. Respir Med 92:473-479 (Pubitemid 28162157)
7. Perng RP, Wu MF, Lin SY, Chen YM, Lin JY, Whang-Peng J (1997) A phase I feasibility and pharmacokinetic study of intrapleural paclitaxel in patients with malignant pleural effusions. Anticancer Drugs 8:565-573
8. van de Molengraft FJ, Vooijs GP (1989) Survival of patients with malignancy-associated effusions. Acta Cytol 33:911-916
9. Lynch TJ Jr (1993) Management of malignant pleural effusions. Chest 103:385S-389S
10. Shaw P, Agarwal R (2004) Pleurodesis for malignant pleural effusions. Cochrane Database Syst Rev (1):CD002916
11. Tohda Y, Iwanaga T, Takada M, Yana T, Kawahara M, Negoro S, Okishio K, Kudoh S, Fukuoka M, Furuse K (1999) Intrapleural administration of cisplatin and etoposide to treat malignant pleural effusions in patients with non-small cell lung cancer. Chemotherapy 45:197-204 (Pubitemid 29213402)
12. Shoji T, Tanaka F, Yanagihara K, Inui K, Wada H (2002) Phase II study of repeated intrapleural chemotherapy using implantable access system for management of malignant pleural effusion. Chest 121:821-824 (Pubitemid 34251448)
13. Lerza R, Vannozzi MO, Tolino G, Viale M, Bottino GB, Bogliolo G, Cerruti A, Castello G, Mencoboni M, Reggiardo G, Pannacciulli I, Esposito M (1997) Carboplatin and cisplatin pharmacokinetics after intrapleural combination treatment in patients with malignant pleural effusion. Ann Oncol 8:385-391 (Pubitemid 27230981)
14. Ichinose Y, Tsuchiya R, Koike T, Yasumitsu T, Nakamura K, Tada H, Yoshimura H, Mitsudomi T, Nakagawa K, Yokoi K, Kato H (2002) A prematurely terminated phase III trial of intraoperative intrapleural hypotonic cisplatin treatment in patients with resected non-small cell lung cancer with positive pleural lavage cytology: the incidence of carcinomatous pleuritis after surgical intervention. J Thorac Cardiovasc Surg 123:695-699 (Pubitemid 34535079)
15. Hausheer FH, Yarbro JW (1985) Diagnosis and treatment of malignant pleural effusion. Semin Oncol 12:54-75
16. Wang X, Zhou J, Wang Y, Zhu Z, Lu Y, Wei Y, Chen L (2010) A phase I clinical and pharmacokinetic study of paclitaxel liposome infused in non-small cell lung cancer patients with malignant pleural effusions. Eur J Cancer 46:1474-1480
17. Jones DR, Taylor MD, Petroni GR, Shu J, Burks SG, Daniel TM, Gillenwater HH (2010) Phase I trial of intrapleural docetaxel administered through an implantable catheter in subjects with a malignant pleural effusion. J Thorac Oncol 5:75-81